ETR:BIO Biotest Aktiengesellschaft (BIO) Stock Price, News & Analysis → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free BIO Stock Alerts €41.60 -0.20 (-0.48%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range€41.60▼€41.6050-Day Range€41.60▼€42.8052-Week Range€39.60▼€44.00Volume28 shsAverage Volume1,927 shsMarket Capitalization$823.26 millionP/E Ratio18.17Dividend Yield0.10%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Biotest Aktiengesellschaft alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Biotest Aktiengesellschaft Stock (ETR:BIO)Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine. Its products include Haemoctin and Vihuma for the treatment of haemophilia A acute therapy and prophylaxis; and Haemonine for haemophilia B acute therapy and prophylaxis. The company's products also comprise Cytotect CP biotest for cytomegalovirus infection; Fovepta for immunoprophylaxis of hepatitis B in neonates; Hepatect for prophylaxis of hepatitis B reinfection; Intratect and Yimmugo for primary immune and secondary antibody deficiency syndromes and autoimmune diseases, including neurological indications; Varitect for the treatment of varicella zoster virus infections; and Zutectra for hepatitis B immunoglobulins. In addition, it provides Albiomin and Biseco to restore and maintain circulating blood volume; Cofact for deficiency of coagulation factors; Fibrinogen to treat congenital fibrinogen deficiency; Trimodulin for the community-acquired pneumonia and COVID-19; and Pentaglobin to treat bacterial infections. The company was formerly known as Biotest Serum-Institut GmbH and changed its name to Biotest Aktiengesellschaft in 1986. The company was founded in 1946 and is headquartered in Dreieich, Germany. Biotest Aktiengesellschaft is a subsidiary of Grifols, S.A.Read More BIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIO Stock News HeadlinesApril 19, 2024 | finanznachrichten.deBiotest baut aus, während Grifols weiter mit Gotham-Schatten kämpft. Ist die Mutter die spannendere Aktie?March 10, 2024 | finance.yahoo.comBiotest Aktiengesellschaft (BIOD.XC)April 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.March 9, 2024 | benzinga.comBiotest AG's Net WorthDecember 13, 2023 | wsj.comBiotest AG Pfd.October 5, 2023 | markets.businessinsider.comEQS-Adhoc: Biotest AG: Peter Janssen appointed new Chairman of the Board of Biotest AGOctober 5, 2023 | finanznachrichten.deEQS-Adhoc: Biotest AG: Erhöhung der EBIT PrognoseOctober 5, 2023 | markets.businessinsider.comEQS-Adhoc: Biotest AG: Increase of the EBIT guidanceApril 19, 2024 | Gold Safe Exchange (Ad)The “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.May 19, 2023 | morningstar.comBiotest AG Pfd Shs - Non-votingMay 18, 2023 | investing.comHangzhou Biotest Biotech Co Ltd (688767)April 28, 2023 | markets.businessinsider.comEQS-Adhoc: Biotest AG: Biotest and Grifols further strengthen their cooperation - EBIT forecast 2023 significantly raisedApril 22, 2023 | wsj.comHangzhou Biotest Biotech Co. Ltd. AMarch 19, 2023 | finanznachrichten.deBiotech Report: Biotest und BB Biotech behauptet, MorphoSys tiefrotMarch 16, 2023 | de.finance.yahoo.comBiotest AG: Biotest spendet Humanalbumin für Erdbebenopfer in der TürkeiMarch 16, 2023 | uk.finance.yahoo.comBiotest AG: Biotest donates human albumin for earthquake victims in TurkeyFebruary 16, 2023 | marketwatch.com2023 Platelet-rich Fibrin Market Growth in 2029 Dominant Forces in Industry with Top Regions and PlayersJuly 27, 2022 | finance.yahoo.comBiotest Aktiengesellschaft (BIO3.DE)March 30, 2022 | finanznachrichten.deALCON AGFebruary 16, 2022 | markets.businessinsider.comDGAP-Adhoc: Biotest AG: Biotest exceeds Revenue guidance 2021January 7, 2022 | markets.businessinsider.comDGAP-Adhoc: Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offerDecember 9, 2021 | uk.finance.yahoo.comBiotest AG: Reduction of guidanceDecember 8, 2021 | markets.businessinsider.comDGAP-Adhoc: Biotest AG: Reduction of guidanceSeptember 19, 2021 | seekingalpha.comGrifols, S.A. (GRFS)See More Headlines Receive BIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotest Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolETR:BIO CUSIPN/A CIKN/A Webwww.biotest.com Phone+49-6103-8010FaxN/AEmployees2,426Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)€2.29 Trailing P/E Ratio18.17 Forward P/E Ratio346.67 P/E GrowthN/ANet Income$90.90 million Net Margins13.87% Pretax MarginN/A Return on Equity22.62% Return on Assets6.39% Debt Debt-to-Equity Ratio151.29 Current Ratio5.00 Quick Ratio1.66 Sales & Book Value Annual Sales$655.60 million Price / Sales1.26 Cash Flow€1.34 per share Price / Cash Flow31.04 Book Value€9.38 per share Price / Book4.43Miscellaneous Outstanding Shares19,790,000Free FloatN/AMarket Cap$823.26 million OptionableNot Optionable Beta0.27 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Peter Janssen (Age 56)CEO & Chairman of the Board of Management Comp: $764kMs. Ainhoa Mendizabal Zubiaga (Age 51)Member of Management Board & CFO Comp: $570kDr. Jorg Schuttrumpf (Age 50)Chief Scientific Officer & Member of the Management Board Comp: $523kDirk Schuck (Age 46)Member of Supervisory Board Dr. Monika ButtkereitHead of Investor RelationsDr. Christina ErbHead of Corporate HRMore ExecutivesKey CompetitorsMorphoSysETR:MORRHÖN-KLINIKUM AktiengesellschaftETR:RHKStratecETR:SBSDrägerwerk AG & Co. KGaAETR:DRW3CompuGroup Medical SE & Co. KGaAETR:COPView All Competitors BIO Stock Analysis - Frequently Asked Questions How have BIO shares performed in 2024? Biotest Aktiengesellschaft's stock was trading at €42.60 on January 1st, 2024. Since then, BIO stock has decreased by 2.3% and is now trading at €41.60. View the best growth stocks for 2024 here. Is Biotest Aktiengesellschaft a good dividend stock? Biotest Aktiengesellschaft (ETR:BIO) pays an annual dividend of €0.04 per share and currently has a dividend yield of 0.18%. The dividend payout ratio is 1.75%. This payout ratio is at a healthy, sustainable level, below 75%. What other stocks do shareholders of Biotest Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biotest Aktiengesellschaft investors own include Grifols (GRFS), CSL (CSL), BioXcel Therapeutics (BTAI) and ADMA Biologics (ADMA). This page (ETR:BIO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotest Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.